FAM
CORT icon

Formidable Asset Management’s Corcept Therapeutics CORT Stock Holding History

Formidable Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Sell
7,828
-3,853
-33% -$233K 0.11% 186
2026
Q1 		$471K Buy
11,681
+5,450
+87% +$204K 0.07% 240
2025
Q4 		$217K Sell
6,231
-2,435
-28% -$191K 0.03% 372
2025
Q3 		$720K Hold
8,666
– – 0.11% 181
2025
Q2 		$636K Buy
8,666
+859
+11% +$62.3K 0.11% 189
2025
Q1 		$892K Buy
+7,807
New +$475K 0.15% 132

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Formidable Asset Management's CORT Position: Q2 2026 in Review

Formidable Asset Management reduced its Corcept Therapeutics (CORT) stake by 33% in Q2 2026, selling an estimated $233K and leaving 7,828 shares worth $681K. The position accounts for 0.11% of the portfolio, ranked #186.

Formidable Asset Management first reported a position in CORT in Q1 2025 and has held it in 6 quarters since. The position peaked at $892K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Formidable Asset Management held 7,828 shares of Corcept Therapeutics worth $681K as of Q2 2026.
  • Formidable Asset Management sold 3,853 Corcept Therapeutics shares in Q2 2026, an estimated $233K.
  • Corcept Therapeutics made up 0.11% of Formidable Asset Management's portfolio in Q2 2026, its #186 holding.
  • Formidable Asset Management first reported a position in Corcept Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Formidable Asset Management's Corcept Therapeutics position peaked at $892K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.